BMND-08

N/A

Report date: 2024/05/30 11:45:51
NME

Base Information

Drug NameBMND-08
Drug Alias Name5-MeO-DMT-Biomind Labs5-methoxy-N,N-dimethyltryptamineN,N-Dimethyl-5-methoxytryptamineO-MethylbufotenineMethoxybufotenin +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor modulators
TargetsSerotonin (5-HT) receptor
Therapy Area/IndicationsBehavior, AddictiveChronic PainAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryArgentinaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiomind Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiomind Labs IncGH Research Ireland Ltd
Inactive CompaniesN/A
Active IndicationsBehavior, AddictiveChronic PainAlzheimer Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG